What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0000894300
Total reported value
$481.2M
$481.2M
46 檔
47.6%
As reported in its official Q4 2024 Form 13F filing, Bender Robert & Associates's tracked investment portfolio stood at $481.2M with 46 total positions.
Bender Robert & Associates executed strategic sector rebalancing during Q4 2024, establishing 8 new positions while fully exiting 1 holdings and trimming 22 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NVDA | Nvidia CORP | Stock-Tech | 18.41% | -0.50% | -14.20% | |
| 2 | AAPL | Apple Inc | Stock-Tech | 15.86% | -0.50% | -35.34% | |
| 3 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 9.15% | -1.92% | -13.92% | |
| 4 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 6.78% | -0.08% | -13.35% | |
| 5 | META | Meta Platforms Inc-class A | Stock-Comm Services | 5.09% | -0.76% | -17.82% | |
| 6 | MELI | Mercadolibre Inc | Stock-Consumer Disc | 4.95% | -0.71% | -10.01% | |
| 7 | LULU | Lululemon Athletica Inc | Stock-Consumer Disc | 3.50% | -0.55% | -31.13% | |
| 8 | LLY | Eli Lilly & Co | Stock-Healthcare | 3.41% | +0.53% | +1.29% | |
| 9 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 3.27% | +0.14% | -13.18% | |
| 10 | NOW | Servicenow Inc | Stock-Tech | 3.00% | -0.25% | -17.77% | |
| 11 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 2.69% | +0.30% | +1.35% | |
| 12 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 2.65% | -0.08% | +0.63% | |
| 13 | ADBE | Adobe Inc | Stock-Tech | 2.44% | -0.38% | -5.88% | |
| 14 | CB | Chubb Limited | Stock-Financials | 2.26% | -0.23% | +0.50% | |
| 15 | ULTA | Ulta Beauty Inc | Stock-Consumer Disc | 2.24% | -0.66% | -13.08% | |
| 16 | BKNG | Booking Holdings Inc | Stock-Consumer Disc | 2.17% | -0.16% | -10.28% | |
| 17 | MSFT | Microsoft CORP | Stock-Tech | 2.06% | -0.20% | +1.75% | |
| 18 | AMD | Advanced Micro Devices | Stock-Tech | 1.81% | +4.32% | -10.17% | |
| 19 | ILMN | Illumina Inc | Stock-Healthcare | 1.15% | +0.27% | -20.10% | |
| 20 | SBUX | Starbucks CORP | Stock-Consumer Disc | 0.98% | -0.01% | +2.67% | |
| 21 | DIS | Walt Disney Co/the | Stock-Comm Services | 0.87% | -0.09% | +0.61% | |
| 22 | HD | Home Depot Inc | Stock-Consumer Disc | 0.82% | -0.04% | +3.06% | |
| 23 | PANW | Palo Alto Networks Inc | Stock-Tech | 0.80% | +1.82% | +109.78% | |
| 24 | FIVE | Five Below | Stock-Consumer Disc | 0.69% | — | -30.84% | |
| 25 | NEE | Nextera Energy Inc | Stock-Utilities | 0.63% | -0.13% | +0.81% | |
| 26 | COST | Costco Wholesale CORP | Stock-Consumer Staples | 0.33% | -0.06% | +3.78% | |
| 27 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.23% | -0.02% | -8.57% | |
| 28 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.19% | — | -12.10% | |
| 29 | ABBV | Abbvie Inc | Stock-Healthcare | 0.18% | +0.01% | -0.74% | |
| 30 | JPM | Jpmorgan Chase & Co | Stock-Financials | 0.16% | -0.01% | -3.30% | |
| 31 | ABT | Abbott Laboratories | Stock-Healthcare | 0.15% | -0.02% | -2.30% | |
| 32 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.13% | -0.02% | +5.09% | |
| 33 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.12% | -0.01% | — | |
| 34 | DE | Deere & Co | Stock-Industrials | 0.10% | — | -0.30% | |
| 35 | CAT | Caterpillar Inc | Stock-Industrials | 0.09% | +0.04% | -0.46% | |
| 36 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.09% | -0.15% | EXIT | |
| 37 | ORCL | Oracle CORP | Stock-Tech | 0.08% | -0.01% | — | |
| 38 | V | Visa Inc-class A Shares | Stock-Financials | 0.08% | -0.06% | EXIT | |
| 39 | NUE | Nucor CORP | Stock-Materials | 0.07% | +0.02% | — | |
| 40 | EOLS | Evolus Inc | Stock-Other | 0.07% | -0.02% | EXIT | |
| 41 | SMMT | Summit Therapeutics Inc | Stock-Other | 0.05% | — | — | |
| 42 | PAYX | Paychex Inc | Stock-Tech | 0.05% | — | — | |
| 43 | PLSE | Pulse Biosciences Inc | Stock-Other | 0.05% | -0.06% | EXIT | |
| 44 | TROW | T Rowe Price Group Inc | Stock-Financials | 0.05% | — | — | |
| 45 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 0.04% | -0.05% | EXIT | |
| 46 | CMRXEUR | Chimerix Inc | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NVDA | Nvidia CORP | +1.3% | -14.20% | Trim |
| 2 | AMZN | Amazon.com Inc | +0.9% | -13.35% | Trim |
| 3 | GOOGL | Alphabet Inc-cl A | +0.6% | +1.35% | Add |
| 4 | BKNG | Booking Holdings Inc | +0.4% | -10.28% | Trim |
| 5 | GOOG | Alphabet Inc-cl C | +0.4% | -13.18% | Trim |
| 6 | ISRG | Intuitive Surgical Inc | +0.3% | -13.92% | Trim |
| 7 | LULU | Lululemon Athletica Inc | +0.3% | -31.13% | Trim |
| 8 | NOW | Servicenow Inc | +0.3% | -17.77% | Trim |
| 9 | MSFT | Microsoft CORP | +0.3% | +1.75% | Add |
| 10 | DIS | Walt Disney Co/the | +0.2% | +0.61% | Add |
| 11 | ULTA | Ulta Beauty Inc | +0.2% | -13.08% | Trim |
| 12 | CB | Chubb Limited | +0.2% | +0.50% | Add |
| 13 | PANW | Palo Alto Networks Inc | +0.2% | +109.78% | Add |
| 14 | URGN | UroGen Pharma Ltd. | +0.1% | NEW | New buy |
| 15 | HD | Home Depot Inc | +0.1% | +3.06% | Add |
| 16 | SBUX | Starbucks CORP | +0.1% | +2.67% | Add |
| 17 | EOLS | Evolus Inc | +0.1% | NEW | New buy |
| 18 | COST | Costco Wholesale CORP | +0.1% | +3.78% | Add |
| 19 | SMMT | Summit Therapeutics Inc | +0.1% | NEW | New buy |
| 20 | PAYX | Paychex Inc | +0.1% | NEW | New buy |
| 21 | PLSE | Pulse Biosciences Inc | +0.1% | NEW | New buy |
| 22 | TROW | T Rowe Price Group Inc | +0.1% | NEW | New buy |
| 23 | BCRX | Biocryst Pharmaceuticals Inc | 0% | NEW | New buy |
| 24 | V | Visa Inc-class A Shares | 0% | +12.86% | Add |
| 25 | JPM | Jpmorgan Chase & Co | 0% | -3.30% | Trim |
| 26 | GILD | Gilead Sciences Inc | 0% | -8.57% | Trim |
| 27 | LLY | Eli Lilly & Co | 0% | +1.29% | Add |
| 28 | CMRXEUR | Chimerix Inc | 0% | NEW | New buy |
| 29 | JNJ | Johnson & Johnson | 0% | +5.09% | Add |
| 30 | CAT | Caterpillar Inc | 0% | -0.46% | Trim |
| 31 | ABT | Abbott Laboratories | 0% | -2.30% | Trim |
| 32 | ORCL | Oracle CORP | 0% | — | Unchanged |
| 33 | DE | Deere & Co | 0% | -0.30% | Trim |
| 34 | ABBV | Abbvie Inc | — | -0.74% | Trim |
| 35 | MRK | Merck & Co. Inc. | — | — | Unchanged |
| 36 | NUE | Nucor CORP | 0% | — | Unchanged |
| 37 | NEE | Nextera Energy Inc | 0% | +0.81% | Add |
| 38 | VRTX | Vertex Pharmaceuticals Inc | 0% | +0.63% | Add |
| 39 | FIVE | Five Below | 0% | -30.84% | Trim |
| 40 | AZNN | Astrazeneca Plc-spons Adr | 0% | -12.10% | Trim |
| 41 | AEP | American Electric Power | 0% | EXIT | Sold out |
| 42 | ILMN | Illumina Inc | -0.1% | -20.10% | Trim |
| 43 | ADBE | Adobe Inc | -0.2% | -5.88% | Trim |
| 44 | META | Meta Platforms Inc-class A | -0.2% | -17.82% | Trim |
| 45 | AMD | Advanced Micro Devices | -0.6% | -10.17% | Trim |
| 46 | MELI | Mercadolibre Inc | -0.9% | -10.01% | Trim |
| 47 | AAPL | Apple Inc | -4.2% | -35.34% | Trim |
According to official SEC Form 13F filings, Bender Robert & Associates reported a total U.S. public equity portfolio value of $481.2M across 46 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NVDA, AAPL, ISRG) accounted for 47.6% of total reported equity market value during Q4 2024.
Top New Position Initiated
URGN
市值: $369.6K
Top Position Liquidated / Trimmed
AEP
前期市值: $210.3K
During Q4 2024, Bender Robert & Associates's top holdings by market value included NVDA (18.4%)、AAPL (15.9%)、ISRG (9.2%). The largest single position, NVDA, represented 18.4% of total portfolio value.
In Q4 2024, Bender Robert & Associates made 44 total portfolio adjustments, initiating 8 new buys, adding to 13 positions, trimming 22 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.